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Abstract
Objective: A high intake of sugar-sweetened beverages (SSB) has been linked
to weight gain, obesity and type 2 diabetes; however, the inﬂuence on CVD risk
remains unclear. Therefore, our objective was to summarize current evidence for an
association between SSB consumption and cardiovascular risk factors and events.
Design: The article search was performed in August 2013. Two independent
researchers performed the article search and selection, data extraction and quality
assessment. Eligible studies reported the intake of SSB and one of the following
outcomes: change in blood pressure, blood lipid or blood sugar, or CVD events
such as stroke or myocardial infarction. Only intervention and longitudinal studies
were included.
Subjects: Only studies in adults (aged 18 + years old) were considered.
Results: Two of four prospective studies found clear direct associations between
SSB consumption and CHD, while two of three studies, including both men and
women, found direct associations between SSB consumption and stroke;
however, the association was signiﬁcant among women only. All included studies
examining vascular risk factors found direct associations between SSB consumption
and change in blood pressure, blood lipid or blood sugar.
Conclusions: The reviewed studies generally showed that SSB intake was related
to vascular risk factors, whereas associations with vascular events were less
consistent. Due to a limited number of published papers, especially regarding
vascular events, the strength of the evidence is still limited and hence more studies
are needed before ﬁrm conclusions can be made.
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Dietary carbohydrates are essential for body functions as
they are the main source of energy. To ensure a balanced
diet, the Institute of Medicine, Food and Nutrition Board
recommends that 45–55% of the total energy intake is
provided by carbohydrates(1). Added sugar (table sugar) is
added to foods and beverages during industrial processing,
and hence refers to sugars that are not naturally occurring(2).
Studies show that added sugar (over-) consumption,
speciﬁcally in the form of sugar-sweetened beverages
(SSB), seems to be linked to different harmful health
outcomes such as obesity and diabetes(3–5). SSB may
also potentially increase the risk of CVD through their high
amount of rapidly absorbable carbohydrates that may,
via an elevated hepatic de novo lipogenesis, result in
hypertension, accumulation of visceral and ectopic fat,
and increased TAG and LDL cholesterol (LDL-C) and
decreased HDL cholesterol (HDL-C) levels(6,7). The
increased glycaemic load caused by a high SSB intake
may lead to inﬂammation, β-cell dysfunction and insulin
resistance, as suggested by Malik et al. (2010) who, in their
pooled meta-analysis from three prospective cohorts,
reported that participants in the highest category of SSB
intake had a 20 % greater risk of developing metabolic
syndrome than those in the lowest category of intake(4).
Most previous literature reviews on potential health conse-
quences of a high intake of SSB have focused on obesity,
metabolic syndrome or diabetes as their outcome of
interest(8–11). Furthermore, of those previous reviews that
assessed associations between SSB consumption and CVD
risk and events, most were not systematic(3,12,13) or did not
Public Health Nutrition: 18(7), 1145–1154 doi:10.1017/S1368980014002122
*Corresponding author: Email amelie.cleo.keller@regionh.dk © The Authors 2014
include a quality assessment of the included studies. For
instance, the systematic review by Sonestedt et al. (2012)
examined the association between sugar intake (SSB,
sucrose and fructose) and type 2 diabetes, CVD and
related metabolic risk factors, but included ﬁve primary
studies (four prospective cohort studies and one rando-
mised controlled trial (RCT)) regarding SSB consumption
and CVD, only(5). Furthermore, Althuis and Weed (2013)
in their more recent review, which included just four
prospective cohort studies on SSB consumption and CHD/
stroke, stressed the need for more updated reviews spe-
ciﬁcally based on results from studies on SSB intake and
CHD and stroke(14). Finally, in a recent review of reviews
that assessed the quality of published reviews regarding
SSB and health, it was concluded that systematic literature
reviews assessing the quality of included studies are
generally lacking(11).
The primary aim of the present systematic review was
therefore to review the results from published studies
examining the association between SSB consumption
and related vascular events and risk factors until 2013.
The secondary aim was to assess the quality of the
original papers included in the review using a validated
quality assessment tool from the Academy of Nutrition and
Dietetics. Finally, we wanted to examine if there was
evidence that the association between SSB consumption
and CVD was mediated by diabetes, hypertension, BMI or
energy intake.
Method
Search methods and terms used
The literature search was performed through the platforms
PubMed/MEDLINE and Web of Knowledge by two inde-
pendent researchers in August 2013. The terms used for
the article search combined key terms for SSB and CVD:
Metabolic Syndrome X, Glucose, Insulin, Subcutaneous Fat,
Abdominal, Intra-Abdominal Fat, Cardiovascular Diseases,
Blood Pressure, Hypertension, Inﬂammation, Protein, Choles-
terol, Triglycerides, Lipoproteins, HOMA, Waist Circum-
ference, Carbonated Beverages, Soda, Dietary Sucrose,
Sucrose, Fructose, Sweetening Agents, Glucose, Energy
Drinks, Beverages, Adult.
Selection of articles
The selection of articles was performed in three steps.
First, papers in the database search were selected based
on their title. Second and third, all abstracts and full texts of
papers identiﬁed in the ﬁrst step were screened by the two
researchers. (For further details, see online supplementary
material: Expanded Method.)
Data extraction and quality assessment
The quality of each study included in the review was
independently assessed by the same two researchers who
selected the papers using the Academy of Nutrition and
Dietetics’ (formerly the American Dietetic Association (ADA))
Quality Criteria Checklist: Primary Search from the ADA
Evidence Analysis Manual(15). (For further details, see online
supplementary material: Expanded Method.)
Selection criteria
The following criteria were used to include or exclude
articles for this systematic literature review.
Exposure. There is no ofﬁcial deﬁnition for SSB; how-
ever, as a convention, SSB are deﬁned as beverages con-
taining added sugar(14,16). In the present review, SSB
include carbonated or non-carbonated sodas, fruit drinks
and sport drinks (Fig. 1). The deﬁnition of SSB used in
each study is given in the online supplementary material,
Supplemental Table 1.
Study design. Longitudinal and intervention studies
were included. Cohort studies had to have a minimum
length of follow-up of 1 year and intervention studies had
to have a follow-up of at least 4 weeks.
Outcome. We included studies looking at SSB con-
sumption in relation to CVD and CVD risk factors such as
change in blood pressure (hypertension), HDL-C, LDL-C,
TAG, blood glucose and insulin resistance, and in relation
to CVD events such as stroke and CHD as they were the only
end points that could be reviewed. (For further details, see
online supplementary material: Expanded Method.)
Subjects. Only studies in adults (aged 18 + years old)
were considered.
Language. English.
Article types. Original articles published up to 31
August 2013.
Time period. The article search was performed in
August 2013.
Caloric drinks (e.g.
alcohol drinks, milk,
100 % fruit juice
Sugar-sweetened 
beverages
Carbonated and non-
carbonated sodas
Fruit drinks and sport
drinks
Fig. 1 Classification of caloric beverages used in the present
review
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Results
The initial literature search resulted in 657 papers. After
the titles and abstracts were screened, the full-text papers
of forty-two articles were screened for the ﬁnal inclusion.
The evaluation of full-text articles resulted in the inclusion
of ten prospective studies and one RCT in the review
(Fig. 2)(17–27). Nine studies included both men and
women(17–25), one study included men only(26) and another
one women only(27). Most studies were from the USA, one
was from Japan(18), one from Spain(25) and another from
Denmark(24). The number of participants ranged from
810 to 97 991 among prospective studies, with ﬁve studies
including more than 30 000 participants(18,19,21,26,27) and
ﬁve less than 10 000 participants(17,20,22,23,25). The RCT
included forty-seven participants(24).
Regarding dietary intake, nine of the eleven included
studies assessed it using an FFQ, one used a 24 h recall(23)
and the RCT used a 7 d record(24). Among prospective
studies, three studies examined change in SSB(23,25,27) and
the others used either a single dietary assessment at
baseline or a cumulative average of SSB intake collected
by multiple FFQ.
In total, ﬁve studies examined associations between
intake of SSB and vascular events; three of these studies
further examined mediating inﬂuences of various vascular
risk factors. In addition, six studies examined associations
between intake of SSB and vascular risk factors.
The list of excluded articles after full-text screening and
reasons for exclusion are given in the online supplemen-
tary material, Supplemental Table 2. The characteristics of
each of the included studies are presented in Tables 1 and 2.
Studies on vascular events
Four papers reported results for CHD, which was deﬁned
as fatal and non-fatal myocardial infarction (MI) in three
of the papers(17,26,27), and as IHD in one paper(18). One
paper reported results for combined vascular events which
included stroke, MI and vascular death(17).
Three studies examined baseline (or cumulative average)
SSB intake and CHD(17,18,26) and one study examined both
baseline SSB intake and change in SSB intake and CHD(27).
Among studies examining baseline (or cumulative
average) SSB intake and CHD, de Koning et al. (2012)
reported that for each additional serving of SSB, the rela-
tive risk (RR) of CHD was 1·19 (95 % CI 1·11, 1·26)(26),
while Fung et al. (2009) found that women who con-
sumed more than two SSB daily had a 39 % greater risk of
developing CHD over the following 24 years (RR= 1·39;
95 % CI 1·11, 1·75; P< 0·001) compared with women who
drank SSB less than once monthly(27). In contrast, the
studies by Eshak et al. (2012) and Gardener et al. (2012)
did not ﬁnd any association between baseline SSB intake
and CHD(17,18). In their analysis of change of SSB intake and
CHD, Fung et al. (2009) found that a 2 servings/d increase
in SSB increased the risk of developing CHD by 28%
(RR=1·28; 95% CI 1·14, 1·44; P<0·001) among women.
Three of ﬁve papers reported results for stroke, which
were classiﬁed either as ischaemic or haemorrhagic or of
unknown type, fatal or non-fatal(17–19). All studies examined
baseline (or cumulative average) SSB intake and stroke.
Bernstein et al. (2012) reported that women consuming
one or more serving of SSB daily were 19 % more likely to
develop stroke (RR= 1·19; 95 % CI 1·00, 1·42) while no
signiﬁcant association was found for men (RR= 1·08; 95 %
CI 0·82, 1·41)(19). Similarly, a high intake of SSB was also
directly associated with an increased risk of stroke for
women (hazard ratio (HR)= 1·39; 95 % CI 1·01, 1·91;
P< 0·01), but an inverse association was found for men
(HR= 0·74; 95 % CI 0·59, 0·96; P= 0·01), in the study by
Eshak et al. (2012)(18). Finally, Gardener et al. (2012) did
not ﬁnd an association between SSB intake and risk of
stroke; however, the authors reported a direct association,
e.g. that a high SSB consumption was associated with an
increased risk of combined vascular events (stroke, MI and
vascular death) among healthier subjects (e.g. those
without obesity, or a history of diabetes or metabolic
syndrome) at baseline. In this subgroup, daily high SSB
intake was associated with an increased risk of vascular
events of 57 % (HR= 1·57; 95 % CI 1·05, 2·35)(17).
In summary, of the ﬁve identiﬁed prospective studies
using vascular events as outcomes(17–19,26,27), two found direct
associations between SSB consumption and CHD(26,27),
two others between SSB consumption and stroke(18,19),
and another one between SSB consumption and combined
vascular events(17).
Studies on mediation of vascular events risk
related to sugar-sweetened beverages consumption
by vascular risk factors
Three of ﬁve studies included potential mediators of the
relationships between SSB consumption and vascular
events in their statistical analysis (Table 1)(18,19,26).
Diabetes and hypertension
Two studies(19,26) adjusted for diabetes in one of their
models and a third study mentioned diabetes as a potential
intermediate risk factor in the pathway between SSB
No. of records identified through database search: 657∗
No. of abstracts screened: 102 No. of abstracts excluded: 60
No. of full-text articles assessed 
for eligibility: 42
No. of full-text articles
excluded with reasons: 31
No. of studies included: 11
Fig. 2 Results of the search. *Four systematic reviews and one
meta-analysis were identified. However, they were not included
in our analysis as only original data were included
Review on soda and vascular disease 1147
Table 1 Description of studies on SSB intake, mediators and risk of vascular events
Reference
(authors and date) Study design
Data set used and
country Gender
No. of participants
analysed Exposure†
Dietary data
collection
method(s) Mediators Outcome Follow-up
Results: association‡ and
RR/HR/OR (95% CI)
Mediation
analysis Quality
CHD de Koning et al.
(2012)(26)
Prospective HPFS, USA M n 42 883 Baseline SSB FFQ DB, HT, TAG,
chol
Incident CHD (fatal
and non-fatal)
22 years + (RR 1·19 (1·11, 1·26))**
(for each additional
serving/d)
No effect (DB &
HT)
A
Eshak et al.
(2012)(18)
Prospective Japan Public
Health Centre-
based cohort I,
Japan
M+F n 39 786 Baseline SSB FFQ EI, BMI IHD 18 years × (M: HR 1·10 (0·77, 1·57;
P= 0·54)) F: HR 0·89
(0·32, 2·45; P= 0·98))
(daily intake v. never)
No effect (BMI &
TEI)
A
Fung et al.
(2009)(27)
Prospective NHS, USA F n 88 520 Change in SSB FFQ DB CHD 24 years + (RR 1·28 (1·14, 1·44))
(2 servings/d increase)
÷ A
Baseline SSB + (RR 1·39 (1·11, 1·75))**
(>2 SSB/d v. < 1 SSB/
month)
Gardener et al.
(2012)(17)
Prospective Northern
Manhattan
Study, USA
M+F n 2564 Baseline SSB FFQ Confounders MI 10 years × (HR 1·26 (0·89, 1·78)) ÷ B
Combined events
(stroke, MI,
vascular death)
+ (non-obese: HR 1·57
(1·05, 2·35))*
(daily intake v. never)
Stroke Bernstein et al.
(2012)(19)
Prospective NHS and HPFS,
USA
M+F NHS: n 84 085
HPFS: n 43 371
Baseline SSB FFQ DB, HT, EI,
BMI
Total stroke NHS: 28
years
HPFS: 22
years
+ (women: RR 1·19 (1·00,
1·42))*
× (men: RR 1·08
(0·82, 1·41))
(daily intake v. never)
Attenuation from
RR 1·19 to
1·14 (P< 0·05)
(DB & HT)
No effect (BMI
& TEI)
A
Eshak et al.
(2012)(18)
Prospective Public Health
Centre-based
cohort I, Japan
M+F n 39 786 Baseline SSB FFQ EI, BMI Total stroke (ischaemic
and haemorrhagic)
18 years + (women: HR 1·39 (1·01,
1·91))**
− (men: HR 0·74 (0·59,
0·96; P= 0·01))
(daily intake v. never)
No effect (BMI &
TEI)
A
Gardener et al.
(2012)(17)
Prospective Northern
Manhattan
Study, USA
M+F n 2564 Baseline SSB FFQ Confounders Total stroke 10 years × (HR 1·00 (0·65, 1·54))
(daily intake v. never)
÷ B
SSB, sugar-sweetened beverages; RR, relative risk; HR, hazard ratio; HPFS, Health Professionals Follow-up Study; NHS, Nurses’ Health Study; M, male; F, female; DB, diabetes; HT, hypertension; chol, cholesterol; EI,
energy intake; MI, myocardial infarction; TEI, total energy intake; ÷, no mediation analysis.
*P< 0·05, **P< 0·01.
†SSB included drinks sweetened with sugar; artificially sweetened beverages and 100% fruit juice were not included.
‡+ , direct association; × , no association; − , inverse association.
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Table 2 Description of studies on SSB intake and associations with vascular risk factors
Reference (authors
and date) Study design
Data set used and
country Gender
No. of participants
analysed Exposure†
Dietary data
collection
method(s) Outcome(s) Follow-up
Results: association‡ and
RR/HR/OR (95% CI) Quality
Hypertension/
high BP
Duffey et al.
(2010)(20)
Prospective CARDIA, USA M+F n 2774 Baseline SSB FFQ+DH BP 20 years + * (RR 1·06 (1·01, 1·12))
(from one quartile to the
next)
A
Cohen et al.
(2012)(21)
Prospective NHS I and II and
HPFS, USA
M+F NHS I: n 88 540
NHS II: n 97 991
HPFS: n 37 360
Baseline SSB FFQ High BP NHS I: 38 years
NHS II: 16 years
HPFS: 22 years
+ (HR 1·13 (1·09, 1·17))
(daily intake v. never)
A
Dhingra et al.
(2007)(22)
Prospective Framingham Offspring
Study, USA
M+F n 6039 Baseline SSB FFQ BP 4 years × (OR 1·18 (0·96, 1·44))
(daily intake v. never)
B
Chen et al.
(2010)(23)
Prospective PREMIER
(intervention)
study), USA
M+F n 810 Change in SSB 24 h recall BP 18 months + * (decrease of 0·7 (0·12,
1·25) mmHg in SBP and
0·4 (0·02, 0·75) mmHg
in DBP)
(decrease of 1 SSB/d)
A
Baseline SSB + (DBP; P=0·01)
× (SBP; P=0·57)
Barrio-Lopez et al.
(2013)(25)
Prospective SUN cohort, Spain M+F n 8157 Change in SSB FFQ BP 6–8 years + ** (OR 1·6 (1·3, 2·1))
(highest v. lowest
quintile)
A
Baseline SSB × (P> 0·05)
Mærsk et al.
(2012)(24)
RCT N/A, Denmark M+F n 47 Intervention Control/
comparison
group
7 d dietary
record
BP 6 months × (P> 0·05) (% change
from baseline to
6 months SSB v. milk,
diet cola, water (data not
shown))
A
Consumption of
1 litre SSB/d
Consumption of
1 litre/d of (i)
ASB (ii) milk
(iii) water
TAG Duffey et al.
(2010)(20)
Prospective CARDIA, USA M+F n 2774 Baseline SSB FFQ+DH TAG 20 years + * (RR 1·06 (1·01, 1·13;
P< 0·05))
(one quartile to the next)
A
Dhingra et al.
(2007)(22)
Prospective Framingham Offspring
Study, USA
M+F n 6039 Baseline SSB FFQ Hypertriacylglycerolaemia 4 years + (OR 1·25 (1·04, 1·51))
(≥1 SSB/d)
B
Barrio-Lopez et al.
(2013)(25)
Prospective SUN cohort, Spain M+F n 8157 Change in SSB FFQ Hypertriacylglycerolaemia 6–8 years + * (OR 1·7 (1·1, 2·6))
(highest v. lowest
quintile)
A
Baseline SSB × (P> 0·05)
Mærsk et al.
(2012)(24)
RCT N/A, Denmark M+F n 47 Intervention Control/
comparison
group
7 d dietary
record
TAG 6 months + * (% change (SD) from
baseline to 6 months:
SSB 32·7 (8·6) v. milk
A
Consumption of
1 litre SSB/d
Consumption of
1 litre/d of (i)
ASB (ii) milk
(iii) water
− 0·301 (8·1), diet cola
− 14·1 (8·1), water
−14·2 (7·7); P=0·001)
Cholesterol Duffey et al.
(2010)(20)
Prospective CARDIA, USA M+F n 2774 Baseline SSB FFQ+DH HDL-C, LDL-C 20 years + * (high LDL-C (RR 1·18
(1·02, 1·36; P< 0·05),
low HDL-C (RR 1·06
(1·02, 1·10; P< 0·05))
(one quartile to the next)
A
Dhingra et al.
(2007)(22)
Prospective Framingham Offspring
Study, USA
M+F n 6039 Baseline SSB FFQ LDL-C 4 years + (OR 1·32 (1·06, 1·64))
(≥1 SSB/d)
B
Barrio-Lopez et al.
(2013)(25)
Prospective SUN cohort, Spain M+F n 8157 Change in SSB FFQ HDL-C 6–8 years × (OR 1·0 (0·7, 1·6))
(highest v. lowest
quintile)
A
Baseline SSB × (P> 0·05)
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and CHD(18). Adjusting for diabetes did not inﬂuence the
associations in the study by de Koning et al. (2012)(26),
whereas Bernstein et al. (2012) in their study found that
the association between SSB intake and stroke risk was
slightly attenuated when controlled for both diabetes and
hypertension. The authors reported that their ﬁndings
suggest that diabetes and hypertension might be mediators
rather than confounders(19). When adjusting for hypertension
as well as for diabetes, the results remained unchanged in
the study by de Koning et al. (2012)(26) (Table 1).
Energy intake and BMI
Energy intake and BMI were considered as mediators and
adjusted for in one model by both Bernstein et al.
(2012)(19) and Eshak et al. (2012)(18); however, no mediation
effects were reported (data not shown). The authors
concluded that BMI and total energy intake were not
major mediators of associations between SSB and vascular
events(18) (Table 1).
Studies on vascular risk factors
The six studies that explored associations between SSB
and vascular risk factors considered hypertension, HDL-C
and LDL-C, TAG, glucose and insulin (homeostasis model
assessment of insulin resistance (HOMA-IR)) in addition to
some obesity outcomes such as visceral adipose tissue
(VAT) and subcutaneous abdominal adipose tissue (SAAT)
in their analyses (Table 2)(20–25).
Four studies examined baseline (or cumulative average)
SSB intake and vascular risk factors(20–22,24) and two others
further examined change in SSB intake and vascular risk
factors(23,25).
Change in SSB consumption over a period of 18 months
was strongly and directly associated with concurrent
changes in systolic blood pressure (SBP) and diastolic
blood pressure (DBP) in the study by Chen et al. (2010).
After adjustment for change in body weight, a reduction of
one serving of SSB (∼350ml) per day was associated with
a concurrent decrease of 0·7 (95 % CI 0·12, 1·25) mmHg
in SBP and 0·4 (95 % CI 0·02, 0·75) mmHg in DBP(23). In
the study by Barrio-Lopez et al. (2013), participants in
the highest quintile of increase in SSB intake over 6-year
follow-up had a higher risk of developing high blood
pressure compared with the lowest quintile (OR= 1·6;
95 % CI 1·3, 2·1)(25). Among studies examining baseline
SSB and vascular risk factors, Cohen et al. (2012) reported
a direct association between high SSB intake and risk of
high blood pressure. In that study, the consumption of one
SSB daily was associated with an adjusted HR of new-
onset hypertension of 1·13 (95 % CI 1·09, 1·17), when
compared with non-drinkers. When analysed separately,
the association between SSB intake and incident hyper-
tension was stronger for women than men (women: aged-
adjusted HR= 1·22; 95 % CI 1·18, 1·27, men: aged-adjusted
HR= 1·39; 95 % CI 1·34, 1·46)(21). Two other studies found
a direct association between SSB intake and hypertensionTa
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or high blood pressure. In the study by Duffey et al.
(2010), higher SSB intake (from one quartile to the next)
was associated with a signiﬁcant increase in the risk of
hypertension (RR= 1·06; 95 % CI 1·01, 1·12)(20). Dhingra
et al. (2007) found that the daily consumption of one or
more servings of SSB was associated with increased odds
of having developed high blood pressure (OR= 1·18; 95 %
CI 0·96, 1·44) at 4-year follow-up. However, this trend was
not statistically signiﬁcant, and the analysis combined SSB
and artiﬁcially sweetened beverage consumption(22). In
contrast, no concurrent changes in blood pressure were
found in the intervention study by Mærsk et al. (2012)
which compared the effect of the intake of one litre of
SSB with those of milk and artiﬁcially sweetened bev-
erages on changes in total fat mass and ectopic fat
deposition(24). Similarly, Barrio-Lopez et al. (2013) did not
ﬁnd any signiﬁcant association between baseline quintile
of SSB and any vascular risk factor(25) and only a small
signiﬁcant increase was reported for DBP but not SBP in
the study by Chen et al. (2010)(23).
The consumption of one or more servings of SSB daily
was found to be associated with increased odds of
hypertriacylglycerolaemia (OR= 1·25; 95 % CI 1·04, 1·51)
and high LDL-C (OR= 1·32; 95 % CI 1·06, 1·64) over the
subsequent four years in the study by Dhingra et al.
(2007)(22). In the Coronary Artery Risk Development in
Young Adults (CARDIA) cohort study, associations
between SSB and 20-year development in HDL-C, LDL-C
and TAG concentrations were examined by Duffey et al.
(2010). In this latter study the authors reported that,
compared with milk or fruit juice consumption, moving
from one quartile of SSB intake to the next was associated
with attainment of high TAG (RR= 1·06; 95 % CI 1·01, 1·13;
P< 0·05), high LDL-C (RR= 1·18; 95 % CI 1·02, 1·36;
P< 0·05) and low HDL-C (RR= 1·06; 95 % CI 1·02, 1·10;
P< 0·05) levels(20). In a third prospective study looking at
change in SSB intake among Spanish men and women,
participants who increased their SSB consumption (upper
v. lower quintile) had signiﬁcantly higher risk of devel-
oping hypertriacylglycerolaemia (OR= 1·7, 95 % CI 1·1,
2·6)(25). Finally, Mærsk et al. (2012) found that mean
relative change from baseline to 6-month follow-up in
TAG (32·7 (SD 8·6) %; P= 0·001), total cholesterol (11·4
(SD 3·2) %; P= 0·004) and VAT/SAAT (18·1 (SD 6·0) %;
P= 0·004) was higher in the intervention group who
consumed one litre of SSB daily compared with that in
the water (TAG: − 14·2 (SD 7·7) %; total cholesterol: − 0·159
(SD 2·8) %; VAT/SAAT: 3·90 (SD 5·7) %), milk (TG: − 0·301
(SD 8·1) %; total cholesterol: 0·634 (SD 3·0) %; VAT/SAAT:
− 12·5 (SD 6·1) %) and artiﬁcially sweetened beverages
groups (TAG: − 14·1 (SD 8·1) %; total cholesterol: − 5·89 (SD
3·0) %; VAT/SAAT: 4·59 (SD 5·5) %)(24).
Impaired fasting blood glucose was directly associated
with SSB intake in the study by Dhingra et al. (2007)
(OR= 1·25; 95 % CI 1·05, 1·48)(22) and in the study by
Barrio-Lopez et al. (2013) (OR= 1·6; 95 % CI 1·1, 2·2)(25),
but not in the prospective study by Duffey et al. (2010)(20).
Finally, no changes in plasma glucose or HOMA-IR were
reported by Mærsk et al. (2012)(24).
In summary, six studies using vascular risk factors as
outcomes found direct associations between baseline or
change in SSB consumption and changes in blood pressure
or lipid metabolism (Table 2)(20–25). Whereas when exam-
ining baseline SSB intake, one study only found a small
direct association with DBP but not SBP(23) and another did
not ﬁnd any signiﬁcant associations.(25)
Quality of studies
Among the eleven identiﬁed studies, nine were of good
quality (quality score: A) and two were of medium quality
(quality score: B); see online supplementary material,
Supplemental Table 3. None of the studies was classiﬁed
with a negative quality score. Quality scores were not
related to the conclusions of the papers about SSB and
CVD. The two studies with a quality score of B were
prospective(17,22). They both had non-detailed descriptions of
exposure and outcome factors or procedures(17,22), and one
study(19) presented some ambiguity regarding outcome deﬁ-
nition and measurements. The strength of the evidence was
graded as ‘fair’ for the association between SSB and vascular
risk factors, and as ‘limited to fair’ for the association between
SSB and vascular events as well as for diabetes, hypertension,
BMI and energy intake as mediators (see online supplemen-
tary material, Supplemental Tables 4 and 5).
Discussion
The present review of the literature linking intake of SSB
to cardiovascular risk factors and events found weak evi-
dence for a direct association between SSB and vascular
events (CHD or stroke). The restricted number of studies
as well as the discrepant results for different subgroups in
relation to stroke limited the strength of this evidence.
However, a high intake of SSB was generally associated
with vascular risk factors, e.g. increased blood pressure
and hyperlipidaemia. Our ﬁndings are in accordance
with the results from Malik et al. (2010) who, based on a
review of ten studies on cardiovascular risk, concluded
that accumulating data suggest a direct association between
SSB intake and the development of hypertension, adverse
lipid parameters, inﬂammation and clinical CHD, although
the evidence is limited(3). More recently, a systematic review
on the impact of SSB on blood pressure from Malik et al.
(2014) showed that SSB intake was directly associated with
high blood pressure and consequent hypertension(28).
In the present review, most studies related to vascular
risk factors found direct associations. The ﬁnding of a
direct association between SSB and subsequent change in
CVD risk factors is further sustained by ﬁndings from a
recent meta-analysis and two smaller short-term RCT that
were not included in the present review as the duration of
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the intervention was < 4 weeks. The meta-analysis by
Huang et al. (2014) of four longitudinal studies on SSB
consumption and CHD risk showed that an increase of
one serving of SSB daily was associated with a 16 %
increased risk of CHD and individuals with the highest SSB
intake had 17 % greater risk of CHD than individuals with
the lowest SSB intake(29). The ﬁrst RCT randomly assigned
twenty-nine subjects to six 3-week interventions assessing
the effects of SSB consumed in small to moderate quan-
tities on lipid and glucose metabolism, and showed a
direct relationship between low to moderate SSB con-
sumption and LDL-C and fasting glucose(30). The second
study found that ingestion of 500 ml of SSB containing 60 g
of fructose increased blood pressure from 30min to 2 h
post-ingestion signiﬁcantly more than did water intake
(P<0·01)(31). The picture is less clear when considering
vascular events rather than vascular risk factors, as some
studies found a direct association(26,27) while others did
not(17,18). Furthermore, few studies examined if differences
in blood pressure, blood lipid and blood sugar were actual
mediators of the associations between SSB and vascular
events, and for those that did so, results were incon-
sistent(19,27). Inconsistent results were also found in regard
to examining diabetes and hypertension as mediators. In
one of the two studies that performed mediation analyses
for diabetes and hypertension, the association between SSB
intake and stroke risk was slightly attenuated(19) whereas the
results remained unchanged in the other study(26). Results
regarding energy intake and BMI were more consistent as no
mediation effects were reported(18,19).
As described earlier, the sugar load contained in SSB may
induce rapid increases in blood sugar, insulin resistance and
lead to changes in lipid proﬁle and blood pressure. In turn,
hyperglycaemia, insulin resistance, increased LDL-C and
TAG may trigger inﬂammation responses and the produc-
tion of free radicals which affect vascular functions(32).
However, as highlighted in the present review, the different
mediating factors in the pathway between SSB consumption
and CVD have not yet been sufﬁciently investigated. Thus,
future studies should examine potential pathways and
mediations of the relationship between SSB consumption
and vascular events, and consider including mediating
factors such as blood pressure, lipid metabolism, blood
sugar and inﬂammation markers to examine and better
understand their role in the pathway between SSB intake
and vascular events.
The source of added sugar in SSB comes from either
sucrose or high-fructose corn syrup, both of which are
composed of 50–55 % fructose (and 45–50 % glucose).
As the metabolic response to fructose differs from that
to glucose, this composition may be of importance in
understanding the association between SSB and CVD.
Fructose has been shown to cause a variety of metabolic
effects such as dyslipidaemia, raised blood pressure and
increased visceral adiposity(33–35), potentially owing to the
facts that (i) unlike glucose, fructose does not need insulin
to be metabolised and (ii) fructose metabolism occurs
more rapidly and almost exclusively in the liver(16,20). Due
to their higher fructose v. glucose content, SSB con-
sumption may be a contributing factor to the incidence of
vascular events(33,36). In the present review, differentiation
between fructose and glucose effects could not be made
and more studies examining relationships between fruc-
tose or glucose and risk of developing vascular events are
needed to determine whether limiting the proportion of
fructose in SSB would be an adequate strategy for the
prevention of vascular events and other chronic diseases.
In general, the evidence for an association between SSB
and stroke seemed stronger for women than for men, with
two studies ﬁnding a direct association among women and
no association among men(18,19). These results are in
agreement with the ﬁndings from the review by Fried and
Rao (2003), who reported that associations between high-
glycaemic-index foods, including beverages such as SSB,
and higher serum TAG concentrations and risk of CHD
were stronger for women(37). The somewhat stronger
associations generally seen for women may relate to
gender differences in lipid and glucose metabolism as well as
hypertension between men and women. Increased CVD
risks have been described primarily in postmenopausal
women. Indeed, premenopausal women have a more
favourable lipoprotein proﬁle and consequently lower CVD
risk relative to similarly aged men, due to the stimulatory
effect of oestrogen and the inhibitory effects of androgen that
disappear after menopause. Consequently, CVD death rates
are two to three times higher among postmenopausal
women than for women of the same age who have not yet
reached menopause and furthermore seem to exceed the
death rates for same-age men(38). (For further details, see
online supplementary material: Expanded Discussion.)
The majority of the included studies had a quality score
of A, indicating a low bias level. The two studies(17,22)
which were graded level B had methodological gaps that
may have affected their conclusion. Despite the majority
of studies being attributed an A score, the total strength
of the evidence was graded ‘limited to fair’ because of
the low number of studies and inconsistent results from
different studies. Regarding vascular events in particular,
only two studies found a direct association between SSB
intake and CHD(26,27) and one study found a direct asso-
ciation for combined vascular events(17). For stroke, results
for women were more consistent, although no associa-
tion was found among the three reviewed studies in
general(17–19). Therefore, to strengthen the evidence, more
well-designed studies are needed. When only quality A
studies are considered, the strength of the evidence
increases from ‘limited to fair’ to ‘fair to good’ regarding
the association between SSB and stroke and decreases
from ‘limited to fair’ to ‘limited’ regarding the association
between SSB and blood glucose. The present review is
the ﬁrst to systematically review published studies on SSB
and CVD with a focus on mediation of associations by
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differences in risk factors such as blood pressure, blood
lipids and blood sugar. Furthermore, the review used a
validated quality assessment tool and the grading of the
strength of the evidence, which provide a more critical
evaluation.
One limitation to our review is the inclusion of only
published articles. Publication bias, favouring studies that
show an association between SSB and CVD, cannot be
excluded and it is possible that the inclusion of unpub-
lished articles and reports would have limited the positive
ﬁndings further. In addition, most included studies, eight
of eleven, were from the USA, and therefore generalisation
to other populations of different racial and ethnic back-
grounds may not be possible.
The majority of included studies (n 10) assessed dietary
intake using an FFQ. Any diet assessment method,
including FFQ, is prone to measurement errors or recall
bias that might lead to over- or underestimation of dietary
intake. Obese people tend to under-report their sugar and
fat intakes more than normal-weight individuals(39,40) and
consequently this may have inﬂated results in some cases.
Therefore, studies included in the review might have
suffered from such bias.
As with any assessment tool, the quality criteria and the
grading of the strength of the evidence checklists of the
Academy of Nutrition and Dietetics (former ADA)(15)
present some limitations, and our quality assessment
approach may hence also introduce some errors. In
addition, assessing the degree of the evidence may be
subject to interpretation and may consequently introduce
some bias. In this regard, the assessment of the quality and
strength of the evidence by two independent researchers
rather than one limits the opportunity for bias.
Conclusion
The strength of the evidence relating SSB and CVD is still
limited. The reviewed papers generally showed discrepant
results for the association between SSB intake and vascular
events, while the evidence for an association between SSB
and vascular risk factors was stronger. However, due to the
limited number of studies investigating these associations
and the discrepant results, further studies are needed.
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